Immunodiagnostic profiling of SPON2 and MSMB as biomarkers in prostate cancer for nanomaterial- based detection strategies
SPON2 and MSMB are secretory, immunogenic biomarkers overexpressed in prostate cancer. Their validated B cell epitopes demonstrate strong diagnostic performance, supporting their potential in nanomaterial-based immunodiagnostic strategies for non-invasive prostate cancer detection.
Authors
- Jianzeng Ye
- Zhuo Fang (ORCID: https://orcid.org/0000-0001-6742-7955)
- Jinquan Xia (ORCID: https://orcid.org/0000-0001-8234-818X)
- Fuhua Zhong
- Jun Zeng (ORCID: https://orcid.org/0009-0005-4031-1297)
Institutions
- Southern University of Science and Technology (CN)
- ShenZhen People’s Hospital (CN)
- Shenzhen Bao'an District People's Hospital (CN)
- Southern Medical University Shenzhen Hospital (CN)
- Shenzhen Second People's Hospital (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-10-22
- DOI
- https://doi.org/10.3389/fimmu.2025.1677562
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00